
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Oncol.
Sec. Cancer Imaging and Image-directed Interventions
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1513193
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objectives: To construct a multiphase contrast-enhanced CT-based radiomics nomogram that combines traditional CT features and radiomics signature for predicting the invasiveness of pancreatic solid pseudopapillary neoplasm (PSPN).Methods: A total of 114 patients with surgical pathologic diagnoses of PSPN were retrospectively included and classified into training (n = 79) and validation sets (n = 35). Univariate and multivariate analyses were adopted for screening traditional CT features significantly associated with the invasiveness of PSPN as independent predictors, and a traditional CT model was established. Radiomics features were extracted from the contrast-enhanced CT images, and logistic regression analysis was employed to establish a machine learning model, including an unenhanced model (model U), an arterial phase model (model A), a venous phase model (model V), and a combined radiomics model (model U+A+V). A radiomics nomogram was subsequently constructed and visualized by combining traditional CT independent predictors and radiomics signature. Model performance was assessed through Delong’s test and receiver operating characteristic (ROC) curve analysis. Decision curve analysis (DCA) was applied to assess the model’s clinical utility.Results: Multivariate analysis suggested that solid tumors (OR = 6.565, 95% CI: 1.238–34.816, P = 0.027) and ill-defined tumor margins (OR = 2.442, 95% CI: 1.038–5.741, P = 0.041) were independent predictors of the invasiveness of PSPN. The areas under the curve (AUCs) of the traditional CT model in the training and validation sets were 0.653 and 0.797, respectively. Among the four radiomics models, the model U+A+V exhibited the best diagnostic performance, with AUCs of 0.857 and 0.839 in the training and validation sets, respectively. In addition, the AUCs of the nomogram in the training and validation sets were 0.87 and 0.867, respectively, which were better than those of the radiomics model and the traditional CT model. The DCA results indicated that with the threshold probability being within the relevant range, the radiomics nomogram offered an increased net benefit to clinical decision making.Conclusion: Multiphase contrast-enhanced CT radiomics can noninvasively predict the invasiveness of PSPN. In addition, the radiomics nomogram combining radiomics signature and traditional CT signs can further improve classification ability.
Keywords: Contrast-enhanced computed tomography (CECT), Radiomics, nomogram, pancreatic solid pseudopapillary neoplasm (PSPN), invasiveness
Received: 18 Oct 2024; Accepted: 20 Mar 2025.
Copyright: © 2025 Ren, Liu, Sun, Wu, Wei, Wang, He, Liu, Zhu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Guoyu Wang, Department of Radiology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.